Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma.
Agdashian D, ElGindi M, Xie C, Sandhu M, Pratt D, Kleiner DE, Figg WD, Rytlewski JA, Sanders C, Yusko EC, Wood B, Venzon D, Brar G, Duffy AG, Greten TF, Korangy F. Agdashian D, et al. Among authors: brar g. Cancer Immunol Immunother. 2019 Apr;68(4):599-608. doi: 10.1007/s00262-019-02299-8. Epub 2019 Jan 28. Cancer Immunol Immunother. 2019. PMID: 30688989 Free PMC article.
Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer.
Xie C, Duffy AG, Mabry-Hrones D, Wood B, Levy E, Krishnasamy V, Khan J, Wei JS, Agdashian D, Tyagi M, Gangalapudi V, Fioravanti S, Walker M, Anderson V, Venzon D, Figg WD, Sandhu M, Kleiner DE, Morelli MP, Floudas CS, Brar G, Steinberg SM, Korangy F, Greten TF. Xie C, et al. Among authors: brar g. Hepatology. 2019 May;69(5):2048-2060. doi: 10.1002/hep.30482. Epub 2019 Mar 10. Hepatology. 2019. PMID: 30578687 Free PMC article. Clinical Trial.
Immunotherapy: Current Status and Future Perspectives.
Floudas CS, Brar G, Greten TF. Floudas CS, et al. Among authors: brar g. Dig Dis Sci. 2019 Apr;64(4):1030-1040. doi: 10.1007/s10620-019-05516-7. Dig Dis Sci. 2019. PMID: 30830521 Review.
A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer.
Floudas CS, Brar G, Mabry-Hrones D, Duffy AG, Wood B, Levy E, Krishnasamy V, Fioravanti S, Bonilla CM, Walker M, Morelli MP, Kleiner DE, Steinberg SM, Figg WD, Greten TF, Xie C. Floudas CS, et al. Among authors: brar g. Clin Colorectal Cancer. 2019 Dec;18(4):e349-e360. doi: 10.1016/j.clcc.2019.06.004. Epub 2019 Jul 2. Clin Colorectal Cancer. 2019. PMID: 31351862 Free PMC article.
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Xie C, Duffy AG, Brar G, Fioravanti S, Mabry-Hrones D, Walker M, Bonilla CM, Wood BJ, Citrin DE, Gil Ramirez EM, Escorcia FE, Redd B, Hernandez JM, Davis JL, Gasmi B, Kleiner D, Steinberg SM, Jones JC, Greten TF. Xie C, et al. Among authors: brar g. Clin Cancer Res. 2020 May 15;26(10):2318-2326. doi: 10.1158/1078-0432.CCR-19-3624. Epub 2020 Jan 29. Clin Cancer Res. 2020. PMID: 31996388 Free PMC article. Clinical Trial.
Correction: Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Xie C, Duffy AG, Brar G, Fioravanti S, Mabry-Hrones D, Walker M, Bonilla CM, Wood BJ, Citrin DE, Gil Ramirez EM, Escorcia FE, Redd B, Hernandez JM, Davis JL, Gasmi B, Kleiner D, Steinberg SM, Jones JC, Greten TF. Xie C, et al. Among authors: brar g. Clin Cancer Res. 2021 Jan 1;27(1):358. doi: 10.1158/1078-0432.CCR-20-4640. Clin Cancer Res. 2021. PMID: 33397682 No abstract available.
Verteporfin synergizes the efficacy of anti-PD-1 in cholangiocarcinoma.
Fu J, McGrath NA, Lee J, Wang X, Brar G, Xie C. Fu J, et al. Among authors: brar g. Hepatobiliary Pancreat Dis Int. 2022 Oct;21(5):485-492. doi: 10.1016/j.hbpd.2022.03.006. Epub 2022 Mar 10. Hepatobiliary Pancreat Dis Int. 2022. PMID: 35307294 Free PMC article.
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma.
Monge C, Xie C, Myojin Y, Coffman-D'Annibale KL, Hrones D, Brar G, Wang S, Budhu A, Figg WD, Cam M, Finney R, Levy EB, Kleiner DE, Steinberg SM, Wang XW, Redd B, Wood BJ, Greten TF. Monge C, et al. Among authors: brar g. Cancer Med. 2024 Feb;13(3):e6912. doi: 10.1002/cam4.6912. Epub 2024 Jan 11. Cancer Med. 2024. PMID: 38205877 Free PMC article.
205 results